Geldof AA - Search Results

1

A cell-based high-throughput screening assay for radiation susceptibility using automated cell counting.

Hodzic J, Dingjan I, Maas MJ, van der Meulen-Muileman IH, de Menezes RX, Heukelom S, Verheij M, Gerritsen WR, Geldof AA, van Triest B, van Beusechem VW. Hodzic J, et al. Among authors: geldof aa. Radiat Oncol. 2015 Feb 27;10:55. doi: 10.1186/s13014-015-0355-2. Radiat Oncol. 2015. PMID: 25888875 Free PMC article.

2

Evaluation of adenoviral oncolytic effect on glioma spheroids by 18F-DG positron-emission tomography.

Idema S, Geldof AA, Dirven CM, van der Jagt M, Gerritsen WR, Vandertop WP, Lamfers ML. Idema S, et al. Among authors: geldof aa. Oncol Res. 2007;16(10):471-7. doi: 10.3727/096504007783338304. Oncol Res. 2007. PMID: 18196871

3

miR-129-3p controls centrosome number in metastatic prostate cancer cells by repressing CP110.

Bijnsdorp IV, Hodzic J, Lagerweij T, Westerman B, Krijgsman O, Broeke J, Verweij F, Nilsson RJ, Rozendaal L, van Beusechem VW, van Moorselaar JA, Wurdinger T, Geldof AA. Bijnsdorp IV, et al. Among authors: geldof aa. Oncotarget. 2016 Mar 29;7(13):16676-87. doi: 10.18632/oncotarget.7572. Oncotarget. 2016. PMID: 26918338 Free PMC article.

4

Cell cycle perturbations and radiosensitization effects in a human prostate cancer cell line.

Geldof AA, Plaizier MA, Duivenvoorden I, Ringelberg M, Versteegh RT, Newling DW, Teule GJ. Geldof AA, et al. J Cancer Res Clin Oncol. 2003 Mar;129(3):175-82. doi: 10.1007/s00432-002-0412-8. Epub 2003 Mar 18. J Cancer Res Clin Oncol. 2003. PMID: 12684891

5

Non‑invasive prostate cancer detection by measuring miRNA variants (isomiRs) in urine extracellular vesicles.

Koppers-Lalic D, Hackenberg M, de Menezes R, Misovic B, Wachalska M, Geldof A, Zini N, de Reijke T, Wurdinger T, Vis A, van Moorselaar J, Pegtel M, Bijnsdorp I. Koppers-Lalic D, et al. Oncotarget. 2016 Apr 19;7(16):22566-78. doi: 10.18632/oncotarget.8124. Oncotarget. 2016. PMID: 26992225 Free PMC article.

6

Radiosensitizing effect of cisplatin in prostate cancer cell lines.

Geldof AA, Slotman BJ. Geldof AA, et al. Cancer Lett. 1996 Mar 29;101(2):233-9. doi: 10.1016/0304-3835(96)04140-7. Cancer Lett. 1996. PMID: 8620475

7

Synergism between cisplatin and radiotherapy in an in vitro prostate tumor cell line.

Geldof AA, Kruit A, Newling DW, Slotman BJ. Geldof AA, et al. Anticancer Res. 1999 Jan-Feb;19(1A):505-8. Anticancer Res. 1999. PMID: 10226589

8

Radiation sensitivity of Copenhagen rat prostatic carcinoma (R3327-AT and R3327-MATLyLu).

Rao BR, Slotman BJ, Geldof AA, Perez CA. Rao BR, et al. Among authors: geldof aa. Int J Radiat Oncol Biol Phys. 1991 May;20(5):981-5. doi: 10.1016/0360-3016(91)90194-9. Int J Radiat Oncol Biol Phys. 1991. PMID: 2022524

9

Cell cycle arrest and clonogenic tumor cell kill by divergent chemotherapeutic drugs.

Mastbergen SC, Duivenvoorden I, Versteegh RT, Geldof AA. Mastbergen SC, et al. Among authors: geldof aa. Anticancer Res. 2000 May-Jun;20(3A):1833-8. Anticancer Res. 2000. PMID: 10928115

10

Decay of γ-H2AX foci correlates with potentially lethal damage repair in prostate cancer cells.

van Oorschot B, Hovingh SE, Rodermond H, Güçlü A, Losekoot N, Geldof AA, Barendsen GW, Stalpers LJ, Franken NA. van Oorschot B, et al. Among authors: geldof aa. Oncol Rep. 2013 Jun;29(6):2175-80. doi: 10.3892/or.2013.2364. Epub 2013 Mar 26. Oncol Rep. 2013. PMID: 23545587

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

73 results

Search Page

Filters